Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 2.5 mg Nicotine Lozenge on Smoking Craving
NCT02357888Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nicotine in nicotine dependence (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Questionnaire for Smoking Urges Brief at 15 minutes. Started Feb 2015; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02357888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357888.